A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
NCT02648906 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 128
Last updated 2016-11-02
Summary
The purpose of this study is to evaluate efficacy and safety of Choline alfoscerate and Donepezil for cognitive improvements of patients with cerebrovascular injury in Alzheimer patients
Conditions
- Alzheimer Disease
Interventions
- DRUG
-
Choline alfoscerate
- DRUG
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 56 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2018-11-30
Countries
- South Korea
More Related Trials
-
A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease
NCT02660983 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
NCT00948909 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
NCT02955706 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
NCT01363648 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia
NCT03441516 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
NCT01082965 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
NCT01023867 ·Status: COMPLETED ·Phase: NA
-
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
NCT02162251 ·Status: COMPLETED
-
Zydena on Cognitive Function of Alzheimer's Disease Patients
NCT01940952 ·Status: UNKNOWN ·Phase: PHASE3
-
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
NCT00988598 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
NCT03249259 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
NCT03363269 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
NCT01129596 ·Status: COMPLETED
-
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
NCT03184467 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease
NCT02899091 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Trial of Donepezil Between the Naive Group and the Switching Group
NCT01023425 ·Status: COMPLETED ·Phase: NA
-
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
NCT00722046 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
NCT07328451 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
NCT02178124 ·Status: COMPLETED ·Phase: PHASE1
-
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
NCT02187276 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01527916 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease
NCT01125683 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
NCT01137526 ·Status: COMPLETED ·Phase: PHASE2
-
Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease
NCT00602680 ·Status: TERMINATED ·Phase: PHASE2